125 related articles for article (PubMed ID: 30472098)
1. EVI-1 modulates arsenic trioxide induced apoptosis through JNK signalling pathway in leukemia cells.
Lang W; Zhu J; Chen F; Cai J; Zhong J
Exp Cell Res; 2019 Jan; 374(1):140-151. PubMed ID: 30472098
[TBL] [Abstract][Full Text] [Related]
2. Arsenic trioxide induces apoptosis in the THP1 cell line by downregulating EVI-1.
Zhou LY; Chen FY; Shen LJ; Wan HX; Zhong JH
Exp Ther Med; 2014 Jul; 8(1):85-90. PubMed ID: 24944602
[TBL] [Abstract][Full Text] [Related]
3. Synergistic killing effects of homoharringtonine and arsenic trioxide on acute myeloid leukemia stem cells and the underlying mechanisms.
Tan M; Zhang Q; Yuan X; Chen Y; Wu Y
J Exp Clin Cancer Res; 2019 Jul; 38(1):308. PubMed ID: 31307525
[TBL] [Abstract][Full Text] [Related]
4. Targeted degradation of the AML1/MDS1/EVI1 oncoprotein by arsenic trioxide.
Shackelford D; Kenific C; Blusztajn A; Waxman S; Ren R
Cancer Res; 2006 Dec; 66(23):11360-9. PubMed ID: 17145882
[TBL] [Abstract][Full Text] [Related]
5. Pathogenetic significance of ecotropic viral integration site-1 in hematological malignancies.
Goyama S; Kurokawa M
Cancer Sci; 2009 Jun; 100(6):990-5. PubMed ID: 19385966
[TBL] [Abstract][Full Text] [Related]
6. Evi-1 as a critical regulator of leukemic cells.
Goyama S; Kurokawa M
Int J Hematol; 2010 Jun; 91(5):753-7. PubMed ID: 20532840
[TBL] [Abstract][Full Text] [Related]
7. Ectopic viral integration Site-1 oncogene promotes NRAS pathway through epigenetic silencing of microRNA-124 in acute myeloid leukemia.
Lang W; Han X; Cai J; Chen F; Xu L; Zhong H; Zhong J
Cell Signal; 2022 Nov; 99():110402. PubMed ID: 35835333
[TBL] [Abstract][Full Text] [Related]
8. Down-regulation of wt1 expression in leukemia cell lines as part of apoptotic effect in arsenic treatment using two compounds.
Glienke W; Chow KU; Bauer N; Bergmann L
Leuk Lymphoma; 2006 Aug; 47(8):1629-38. PubMed ID: 16966277
[TBL] [Abstract][Full Text] [Related]
9. ASK1 is activated by arsenic trioxide in leukemic cells through accumulation of reactive oxygen species and may play a negative role in induction of apoptosis.
Yan W; Arai A; Aoki M; Ichijo H; Miura O
Biochem Biophys Res Commun; 2007 Apr; 355(4):1038-44. PubMed ID: 17331470
[TBL] [Abstract][Full Text] [Related]
10. Expression of the Zn finger gene, EVI-1, in acute promyelocytic leukemia.
Xi ZF; Russell M; Woodward S; Thompson F; Wagner L; Taetle R
Leukemia; 1997 Feb; 11(2):212-20. PubMed ID: 9009083
[TBL] [Abstract][Full Text] [Related]
11. Increased cellular glutathione and protection by bone marrow stromal cells account for the resistance of non-acute promylocytic leukemia acute myeloid leukemia cells to arsenic trioxide in vivo.
Lee C; Lin Y; Huang M; Lin C; Liu C; Chow J; Liu HE
Leuk Lymphoma; 2006 Mar; 47(3):521-9. PubMed ID: 16396776
[TBL] [Abstract][Full Text] [Related]
12. Evi-1 Influence on Clinical Progress of Colorectal Cancer Patients.
Zhu Y; Zhang J; Ye Z; Peng P; Lan X; Xie L; Qin M; Huang J
Ann Clin Lab Sci; 2020 May; 50(3):354-360. PubMed ID: 32581025
[TBL] [Abstract][Full Text] [Related]
13. The effect of simultaneous administration of arsenic trioxide and microvesicles derived from human bone marrow mesenchymal stem cells on cell proliferation and apoptosis of acute myeloid leukemia cell line.
Abbaszade Dibavar M; Soleimani M; Atashi A; Rassaei N; Amiri S
Artif Cells Nanomed Biotechnol; 2018; 46(sup3):S138-S146. PubMed ID: 30600718
[TBL] [Abstract][Full Text] [Related]
14. A critical role of epigenetic inactivation of miR-9 in EVI1
Mittal N; Li L; Sheng Y; Hu C; Li F; Zhu T; Qiao X; Qian Z
Mol Cancer; 2019 Feb; 18(1):30. PubMed ID: 30813931
[TBL] [Abstract][Full Text] [Related]
15. Induction of B-chronic lymphocytic leukemia cell apoptosis by arsenic trioxide involves suppression of the phosphoinositide 3-kinase/Akt survival pathway via c-jun-NH2 terminal kinase activation and PTEN upregulation.
Redondo-Muñoz J; Escobar-Díaz E; Hernández Del Cerro M; Pandiella A; Terol MJ; García-Marco JA; García-Pardo A
Clin Cancer Res; 2010 Sep; 16(17):4382-91. PubMed ID: 20534739
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA-204 Potentiates the Sensitivity of Acute Myeloid Leukemia Cells to Arsenic Trioxide.
Wang Z; Fang Z; Lu R; Zhao H; Gong T; Liu D; Hong L; Ma J; Zhang M
Oncol Res; 2019 Sep; 27(9):1035-1042. PubMed ID: 30982490
[TBL] [Abstract][Full Text] [Related]
17. Identifying arsenic trioxide (ATO) functions in leukemia cells by using time series gene expression profiles.
Yang H; Lin S; Cui J
Gene; 2014 Feb; 535(2):312-7. PubMed ID: 24262935
[TBL] [Abstract][Full Text] [Related]
18. Blockage of JNK pathway enhances arsenic trioxide-induced apoptosis in human keratinocytes.
Huang HS; Liu ZM; Hong DY
Toxicol Appl Pharmacol; 2010 Apr; 244(2):234-41. PubMed ID: 20074581
[TBL] [Abstract][Full Text] [Related]
19. Combination of arsenic trioxide and Dasatinib: a new strategy to treat Philadelphia chromosome-positive acute lymphoblastic leukaemia.
Wang T; Cheng C; Peng L; Gao M; Xi M; Rousseaux S; Khochbin S; Wang J; Mi J
J Cell Mol Med; 2018 Mar; 22(3):1614-1626. PubMed ID: 29266867
[TBL] [Abstract][Full Text] [Related]
20. Salvianolic Acid A Protects H9c2 Cells from Arsenic Trioxide-Induced Injury via Inhibition of the MAPK Signaling Pathway.
Zhang JY; Sun GB; Luo Y; Wang M; Wang W; Du YY; Yu YL; Sun XB
Cell Physiol Biochem; 2017; 41(5):1957-1969. PubMed ID: 28391263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
